Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states

Journal of Pharmaceutical Sciences

Volumn 98, Issue 3, 2009, Pages 1177-1192

  Clarysse, S ^a   Tack, J ^b   Lammert, F ^c   Duchateau, G ^d   Reppas, C ^e   Augustijns, P ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c SAARLAND UNIVERSITY   (Germany)

^d UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

Food interactions; Gastrointestinal; Intestinal absorption; Lipids lipoproteins; Solubility

Indexed keywords

BILE SALT; FATTY ACID; LIPID; LIPOPROTEIN; MONOACYLGLYCEROL; PHOSPHOLIPID;

ARTICLE; CONTROLLED STUDY; DISSOLUTION; DUODENUM FLUID; FOOD INTAKE; HUMAN; INTESTINE ABSORPTION; LIPOLYSIS; NUTRITIONAL STATUS; OSMOLALITY; PH MEASUREMENT; SURFACE TENSION;

EID: 62849112101     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21502     Document Type: Article

References (40)

1. Brouwers J, Ingels F, Tack J, Augustijns P. 2005. Determination of intraluminal theophylline concentrations after oral intake of an immediate-and a slow-release dosage form. J Pharm Pharmacol 57:987-996.
2. Brouwers J, Tack J, Lammert F, Augustijns P. 2006. Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: A case study with amprenavir. J Pharm Sci 95:372-383.
3. Brouwers J, Tack J, Augustijns P. 2007. Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state. Pharm Res 24:1862-1869.
4. Dressman JB, Vertzoni M, Goumas K, Reppas C. 2007. Estimating drug solubility in the gastrointestinal tract. Adv Drug Deliv Rev 59:591-602.
5. Galia E, Nicolaides E, Hörter D, Löbenberg R, Reppas C, Dressman JB. 1998. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 15:698-705.
6. Vertzoni M, Dressman J, Butler J, Hempenstall J, Reppas C. 2005. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm 60:413-417.
7. Ilardia-Arana D, Kristensen HG, Müllertz A. 2006. Biorelevant dissolution media: Aggregation of amphiphiles and solubility of estradiol. J Pharm Sci 95:248-255.
8. Boni JE, Brickl RS, Dressman J. 2007. Is bicarbonate buffer suitable as a dissolution medium? J Pharm Pharmacol 59:1375-1382.
9. Fujioka Y, Kadono K, Fujie Y, Metsugi Y, Ogawara K, Higaki K, Kimura T. 2007. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: Utilization of a more suitable medium for in-vitro dissolution study. J Control Release 119:222-228.
10. Vertzoni M, Fotaki N, Kostewicz E, Stippler E, Leuner C, Nicolaides E, Dressman J, Reppas C. 2004. Dissolution media simulating the intralumenal composition of the small intestine: Physiological issues and practical aspects. J Pharm Pharmacol 56:453-462.
11. Kalantzi L, Persson E, Polentarutti B, Abrahamsson B, Goumas K, Dressman JB, Reppas C. 2006. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res 23:1373-1381.
12. Armand M, Borel P, Pasquier B, Dubois C, Senft M, Andre M, Peyrot J, Salducci J, Lairon D. 1996. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 271:G172-G183.
13. Persson EM, Gustafsson A, Carlsson AS, Nilsson RG, Knutson L, Forsell P, Hanisch G, Lennernäs H, Abrahamsson B. 2005. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res 22:2141-2151.
14. Nielsen PB, Müllertz A, Norling T, Kristensen HG. 2001. The effect of alpha-tocopherol on the in vitro solubilisation of lipophilic drugs. Int J Pharm 222:217-224.
15. Christensen JØ, Schultz K, Mollgaard B, Kristensen HG, Mullertz A. 2004. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur J Pharm Sci 23:287-296.
16. Grove M, Pedersen GP, Nielsen JL, Müllertz A. 2005. Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats - Effect of medium and long chain triglycerides. J Pharm Sci 94:1830-1838.
17. Porter CJH, Trevaskis NL, Charman WN. 2007. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6:231-248.
18. Evans DF, Wennerström H. 1999. Micellar solutions play a key role in many industrial and biological processes. In: Evan DF, Wennerström H, editors. The colloidal domain: Where physics, chemistry, biology and technology meet. 2nd edition. New York: VCH Publishers Inc. pp 198-216.
19. Kalantzi L, Goumas K, Kalioras V, Abrahamsson B, Dressman JB, Reppas C. 2006. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 23:165-176.
20. Müller-Lissner SA, Fimmel CJ, Will N, Müller-Duysing W, Heinzel F, Blum AL. 1982. Effect of gastric and transpyloric tubes on gastric emptying and duodenogastric reflux. Gastroenterology 83:1276-1279.
21. Lütjohann D, Hahn C, Prange W, Sudhop T, Axelson M, Sauerbruch T, von Bergmann K, Reichel C. 2004. Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men. Int J Clin Pharmacol Ther 42:307-313.
22. Gurantz D, Laker MF, Hofmann AF. 1981. Enzymatic measurement of choline-containing phospholipids in bile. J Lipid Res 22:373-376.
23. Duchateau G, Janssen H, Louter A. 2004. Plant sterol analysis in relation to functional foods. In: Dutter PD, editor. Phytosterols as functional food components and nutraceuticals. New York - Basel: Marcel Dekker Inc. pp 75-131.
24. Perez de la Cruz Moreno M, Oth M, Deferme S, Lammert F, Tack J, Dressman J, Augustijns P. 2006. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 58:1079-1089.
25. Dressman JB, Berardi RR, Dermentzoglou LC, Russell TL, Schmaltz SP, Barnett JL, Jarvenpaa KM. 1990. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 7:756-761.
26. Press AG, Hauptmann IA, Hauptmann L, Fuchs B, Fuchs M, Ewe K, Ramadori G. 1998. Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther 12:673-678.
27. Hernell O, Staggers JE, Carey MC. 1990. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 29:2041-2056.
28. Schiller C, Fröhlich C, Giessmann T, Siegmund W, Mönnikes H, Hosten N, Weitschies W. 2005. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 22:971-979.
29. Macheras P, Dokoumetzidis A. 2000. On the heterogeneity of drug dissolution and release. Pharm Res 17:108-112.
30. Macheras P, Argyrakis P. 1997. Gastrointestinal drug absorption: Is it time to consider heterogeneity as well as homogeneity? Pharm Res 14:842-847.
31. Persson EM, Nilsson RG, Hansson GI, Löfgren LJ, Libäck F, Knutson L, Abrahamsson B, Lennernäs H. 2006. A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine. Pharm Res 23:742-751.
32. McHugh PR, Moran TH. 1979. Calories and gastric emptying: A regulatory capacity with implications for feeding. Am J Physiol 236:R254-R260.
33. Ladas SD, Isaacs PE, Murphy GM, Sladen GE. 1984. Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man. Gut 25:405-411.
34. Lindahl A, Ungell AL, Knutson L, Lennernäs H. 1997. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res 14:497-502.
35. Froehlich F, Gonvers JJ, Fried M. 1995. Role of nutrient fat and cholecystokinin in regulation of gallbladder emptying in man. Dig Dis Sci 40:529-533.
36. Stone BG, Ansel HJ, Peterson FJ, Gebhard RL. 1992. Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology 15:795-798.
37. Mansbach CM II, Cohen RS, Leff PB. 1975. Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man. J Clin Invest 56:781-791.
38. Deferme S, Tack J, Lammert F, Augustijns P. 2003. P-glycoprotein attenuating effect of human intestinal fluid. Pharm Res 20:900-903.
39. Gisolfi CV, Summers RW, Lambert GP, Xia T. 1998. Effect of beverage osmolality on intestinal fluid absorption during exercise. J Appl Physiol 85:1941-1948.
40. Jantratid E, Janssen N, Reppas C, Dressman J. 2008. Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update. Pharm Res 25:1663-1676.